Given their critical roles in immune regulation, tumor growth, metastasis, and bone remodeling, interleukins, such as IL-6, IL-8, IL-1β, and IL-11, have been useful in predicting the clinical stage and prognosis of patients with breast cancer which has metastasized to the bone [6]. The gene discussed is CXCL8; the disease is neoplasm.